Sign Up Today and Learn More About GI Innovation Stock
Invest in or calculate the value of your shares in GI Innovation or other pre-IPO companies through EquityZen's platform.

GI Innovation Stock (GIIN)
GI Innovation is a global leader of microbiome drug development.
About GI Innovation Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
GI Innovation Press Mentions
Stay in the know about the latest news on GI Innovation
Fusion protein comprising anti-cd73 antibody and il-2, and use thereof
patents • May 04, 2025
Pharmaceutical composition for treatment of cancer, comprising immune …
patents • May 04, 2025
Pharmaceutical composition for the treatment of cancer comprising fusion …
patents • Apr 02, 2025
Immuno-Oncology Market is Predicted to Reach US$ 111.64 Billion by 2034, Expanding at a CAGR of 16.5% | Fact.MR
einpresswire • Mar 13, 2025
Fusion protein comprising anti-cd73 antibody and il-2, and use thereof
patents • Feb 08, 2025
GI Innovation Management
Leadership team at GI Innovation
Founder & Chairman
Myoung Ho Jang
CEO
Hong Joon-ho

Join now and verify your accreditation status to gain access to:
- GI Innovation Current Valuation
- GI Innovation Stock Price
- GI Innovation Management
- Available deals in GI Innovation and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- GI Innovation Cap Table and Funding History by Share Class and Liquidity Preferences
- GI Innovation Revenue and Financials
- GI Innovation Highlights
- GI Innovation Business Model
- GI Innovation Risk Factors
- GI Innovation Research Report from SACRA Research
Trading GI Innovation Stock
How to invest in GI Innovation stock?
Accredited investors can buy pre-IPO stock in companies like GI Innovation through EquityZen funds. These investments are made available by existing GI Innovation shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell GI Innovation stock?
Shareholders can sell their GI Innovation stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."